Shopping Cart
- Remove All
- Your shopping cart is currently empty
VP3.15 dihydrobromide is a potent, orally bioavailable, and CNS-penetrant dual inhibitor of phosphodiesterase (PDE7) and glycogen synthase kinase (GSK)3, with IC50 values of 1.59 μM and 0.88 μM, respectively.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $38 | In Stock | |
10 mg | $58 | In Stock | |
25 mg | $137 | In Stock | |
50 mg | $238 | In Stock | |
100 mg | $353 | In Stock | |
200 mg | $493 | In Stock | |
1 mL x 10 mM (in DMSO) | $44 | In Stock |
Description | VP3.15 dihydrobromide is a potent, orally bioavailable, and CNS-penetrant dual inhibitor of phosphodiesterase (PDE7) and glycogen synthase kinase (GSK)3, with IC50 values of 1.59 μM and 0.88 μM, respectively. |
Targets&IC50 | GSK-3:0.88 μM, PDE7:1.59 μM |
Molecular Weight | 528.3 |
Formula | C20H24Br2N4OS |
Cas No. | 1281681-33-1 |
Smiles | Br.Br.C(CN1CCOCC1)\N=c1\nc(-c2ccccc2)n(s1)-c1ccccc1 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
Solubility Information | DMSO: 22.5 mg/mL (42.59 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.